Silence of p15 expression by RNAi enhances cisplatin resistance in hepatocellular carcinoma cells
The insensitivity of hepatocellular carcinoma to chemotherapy is associated with alternation in tumor cell cycling. This current study was designed to investigate the impact of p15 silencing on the sensitivity of Human hepatocellular carcinoma HepG2 cells to cisplatin. HepG2/CDDP/1.6 and HepG2/CDDP/...
Main Authors: | Dianliang Fang, Yuanhong Guo, Zhenshuang Zhu, Weiqing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2012-02-01
|
Series: | Bosnian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://www.bjbms.org/ojs/index.php/bjbms/article/view/2523 |
Similar Items
-
Knockdown of cyclooxygenase-2 leads to growth inhibition and cell cycle arrest in hepatocellular carcinoma cells
by: Lv X, et al.
Published: (2019-05-01) -
Circulating levels of growth differentiation factor 15 and sex hormones in male patients with HBV-associated hepatocellular carcinoma
by: Juanjuan Chen, et al.
Published: (2020-01-01) -
Lentivirus-mediated knockdown of P27RF-Rho inhibits hepatocellular carcinoma cell growth
by: Shuli Xie, et al.
Published: (2017-03-01) -
Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma
by: Jee Eun Yang, et al.
Published: (2014-03-01) -
Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver
by: Guozhen Cui, et al.
Published: (2018-07-01)